The EFNA1 gene helps nearby cells communicate so tissues can grow in an organized way and form blood vessels. If it does not work properly, cell movement and tissue patterning can be disrupted. In medicine, this gene is important because it also affects signals that may support tumor growth and spread in some cancers. EFNA1 is mostly known in research rather than public culture.
What is a gene?
A gene is a stretch of DNA that carries information your cells use to make molecules or guide processes in the body. Some genes provide the instructions for making proteins, the parts of cells that do the work. Other genes mainly regulate when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. You can explore this topic in more depth in the LearnHub.
Overview
EFNA1Gene function
What if the gene works
The EFNA1 gene helps nearby cells communicate and keep tissues organized. Its protein sends signals through cell surface receptors that guide cell movement, blood vessel growth, and normal development.
Risk
What if the gene does not work
When the EFNA1 gene works less well, signals that help nearby cells attach, move, and organize can be disrupted. Milder variants may partly weaken this signaling, while more severe variants can reduce it more.
Treatment
What does that mean for your treatment
No EFNA1-specific treatment or management approach is currently established in clinical guidelines. The EFNA1 gene is being studied as a possible biomarker and drug target in some cancers, but this has not yet changed routine care.
Gene function
What if the gene works
Your cells use the EFNA1 gene for close range communication with nearby cells. Its protein sits on the cell surface and passes signals when cells touch. These signals help guide cell position, movement, and tissue shape. They also support normal blood vessel growth.
The EFNA1 gene helps neighboring cells exchange contact based signals through Eph receptors, a family of cell surface signal receivers. This is a key part of EFNA1 gene function in cell communication and keeps local cell behavior coordinated.
These signals help cells know where they belong and how to line up with nearby cells. This supports orderly tissue structure as the body grows, renews surfaces, and maintains clear boundaries between cell groups.
The EFNA1 gene helps fine tune how cells shift position when they meet other cells. This lets movement stay coordinated rather than random, which is important during normal tissue shaping and repair.
EFNA1 activity supports the growth and remodeling of blood vessels by guiding the cells that line them. This helps tissues receive a steady blood supply during everyday maintenance and healing.
What is a variant?
A genetic variant is a small change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the EFNA1 gene can change how much ephrin-A1 reaches the cell surface or how well it binds EPHA receptors on nearby cells. This is central to how EFNA1 gene variants affect protein function, because altered shape, poor stability, or faulty membrane attachment can weaken cell-to-cell signaling. Milder variants may leave some activity intact, while more severe variants can markedly reduce signaling or stop the protein from working at the cell surface.
How variants are linked to conditions
Current evidence on what conditions are linked to EFNA1 gene variants is still developing, and EFNA1 does not yet have a broadly confirmed link to one specific health condition. If you carry an EFNA1 variant, your doctor or genetic counselor can explain what that result may mean in the context of your personal and family history.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widespread in the general population. Most do not directly affect health and instead reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when several genes and environmental influences are involved. In some situations, though, one well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the EFNA1 gene. If EFNA1 appears on a genetic test, its meaning usually depends on the exact change found and the wider clinical picture, so personal risk is best discussed with a doctor or genetic counselor.
Inheritance of EFNA1 variants
There is not yet a broadly confirmed Mendelian pattern for how EFNA1 gene variants are inherited in relation to a specific human condition, so EFNA1 gene inheritance is not described as clearly autosomal dominant, autosomal recessive, or X linked. Research on how EFNA1 gene variants are inherited may become clearer as evidence grows. The EFNA1 gene is located on chromosome 1, which is an autosome, so each person inherits one copy from each parent.
What does my EFNA1 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific inherited condition for EFNA1. If you have a specific EFNA1 result and want to understand what it could mean for close relatives, a doctor or genetic counselor can review the exact finding and your family history together.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for EFNA1 variants usually uses a blood or saliva sample. A lab reads the DNA in the EFNA1 gene to look for changes and reports whether a variant was found, which can help clarify whether EFNA1 is likely part of a person’s health picture.
When should I consider getting a genetic test?
There is not yet a widely used, EFNA1-specific reason for genetic testing in routine care. Testing decisions are usually based on your own health history, family history, and whether a doctor or genetic counselor thinks a broader genetic test would be more helpful.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they explain varies by the condition and the kind of variant involved. Over time, many factors also influence how the body works, including lifestyle, environment, age, and medical history. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best considered together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in DNA can change how a drug is absorbed, broken down, transported, or how strongly it acts on its target. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in some people.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences can shape how someone responds to a medicine. By studying links between genes and medications, it helps explain why the same treatment may affect people differently. For many drugs, genes influence both how strongly a medicine works and how the body handles it. This information can support treatment choices that are more informed and more personalized. More detail on this topic is available in the LearnHub.
Drugs influenced by the EFNA1 gene
When should I seek medical advice?
There is no widely accepted medicine-response use for this gene at this time, so general medication questions or new side effects are best discussed with your doctor. In research, EFNA1 has been studied in cancer care because it affects cell signals linked to tumor growth and new blood vessel formation, but this has not become routine guidance for choosing or adjusting treatment.
History
The EFNA1 gene entered the scientific literature in the early 1990s, when researchers studying cell signaling and growth control identified a small surface protein later called ephrin-A1. Early reports also linked it to a name used at the time, B61, before gene naming became more standardized. Building on this early work, scientists recognized EFNA1 as part of the larger ephrin and Eph receptor family, which became an important area of developmental biology research. As medical science evolved, so did understanding of this gene. Interest in EFNA1 grew further as studies explored its part in blood vessel growth and cancer biology. These historical steps shaped today’s understanding of EFNA1 as a well-established signaling gene.